Rapid testing company Ellume’s big biotech IPO still on table
SYDNEY: There’s at least one $600 million-plus biotech still testing the IPO waters in 2022.
SYDNEY: There’s at least one $600 million-plus biotech still testing the IPO waters in 2022.
FEATURED
Plan unveiled to replace former care home with 24 modern retirement flats
Modernist architecture now set to meet affordable housing for seniors
Land carve-ups help build better housing future for remote communities
Best retirement housing design for Global Awards shortlisted
Boomers high-rise set to come with a health hub
Cohousing trend continues to increase its sway over ageing boomers
INNOVATION
